Neurocrine Biosciences Inc. (NBIX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 665 |
| % of all portfolios: | 0.001% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q2 2024 | |||||
| ≡ | Dodge & Cox | Add 0.74% | 5,140 | 0.00 | |
| Q4 2023 | |||||
| ≡ | Dodge & Cox | Add 388.41% | 552,818 | 0.07 | |
| Q3 2023 | |||||
| ≡ | Dodge & Cox | Buy | 142,330 | 0.02 | |
| Q3 2018 | |||||
| ≡ | Meridian Contrarian Fund | Sell 100.00% | 109,022 | 1.69 | |
| Q2 2018 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 9.16% | 11,000 | 0.17 | |
| Q1 2018 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 13.67% | 19,000 | 0.26 | |
| Q1 2017 | |||||
| ≡ | Meridian Contrarian Fund | Add 16.80% | 20,000 | 0.17 | |
| Q3 2015 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 32.34% | 56,884 | 0.42 | |
| Q2 2015 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 32.45% | 84,504 | 0.65 | |
| Q1 2015 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 37.97% | 159,390 | 0.97 | |
| Q4 2014 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 20.39% | 107,500 | 0.37 | |
| Q3 2014 | |||||
| ≡ | Meridian Contrarian Fund | Add 2.93% | 15,000 | 0.04 | |
| Q2 2014 | |||||
| ≡ | Meridian Contrarian Fund | Add 15.64% | 69,300 | 0.15 | |
| Q1 2014 | |||||
| ≡ | Meridian Contrarian Fund | Add 14.18% | 55,000 | 0.12 | |
| Q4 2013 | |||||
| ≡ | Meridian Contrarian Fund | Buy | 388,000 | 0.49 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.